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Carotid intima media thickness in older children
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therapy
Edith D. Majonga, PhDa,b,
∗
, Scott T. Chiesa, PhDc, Grace McHugh, MDa, Hilda Mujuru, MMedd,
Kusum Nathoo, MMedd, Jon Oyvind Odland, PhDe,f, Juan Pablo Kaski, MD(Res), FRCP, FESCc,g,
Rashida A. Ferrand, PhDa,b
Abstract
Increased carotid intima-media thickness (cIMT) is reported in both adults and children with human immunodeficiency virus (HIV) in
high income settings and is associated with an increased risk of cardiovascular disease, but data from sub-Saharan Africa is lacking.
We assessed cIMT using ultrasound in perinatally HIV-infected children aged 6 to 16 years taking antiretroviral therapy (ART) for≥6
months compared with HIV-uninfected controls in Harare, Zimbabwe. Groups were compared using unpaired t test and potential
predictors of cIMT were assessed using multiple linear regression.
A total of 117 participants with HIV, of whom 55 (45%) were female and 75 healthy uninfected controls were included. Participants
with HIV were younger than uninfected controls, 10.7 (2.4) years versus 11.9 (2.6) years (P= .001). Mean cIMT was 0.40 (0.05)mm in
those with HIV versus 0.40 (0.04)mm in healthy controls (P= .377). There was no association between cluster of differentiation 4
count, HIV viral load, and duration on ART and cIMT.
Children with HIV taking ART have similar cIMT to uninfected children. Increasing numbers of children with HIV are reaching
adulthood and longitudinal studies to assess the effect of long-term HIV and ART on vascular changes are required.
Abbreviations: ART = antiretroviral therapy, BMI = body mass index, BP = blood pressure, cIMT = carotid intima-media
thickness, NNRTI = non-nucleoside reverse transcriptase, NRTI = nucleoside reverse transcriptase, PI = protease inhibitor, SSA =
Sub-Saharan Africa.
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1. Introduction
Carotid intima media thickness (cIMT) is a surrogate marker for
atherosclerosis.[1] Subclinical arterial wall alterations may be
progressive and precede the development of atherosclerosis.
human immunodeficiency virus (HIV) is associated with increased
cIMT in both adults and children in reports from high income
settings.[2,3] Few studies have been conducted in children in Sub-
Saharan African (SSA), where 90% of the world’s children with
HIV live, and findings fromhigh-income settingsmay differ to SSA
children due to variations in access to antiretroviral therapy (ART)
as well as racial differences that have been described before.[4]
Notably, a significant proportion of children and adolescents with
perinatal HIV in SSA have had delayed diagnosis of HIV and/or
ART initiation compared with those from high income settings,
and this may impact on cardiovascular disease risk. Therefore, the
aim of this study was to assess cIMT in children with HIV and
receiving ART in an SSA setting.
2. Methods
The study was part of a larger cohort study to investigate
cardiorespiratory disease in older children with HIV taking ART.
Cardiac and lung findings have been published and the full protocol
has been described elsewhere.[5,6] Participants were recruited from
the pediatric HIV clinic at Harare Hospital, the main public sector
hospital in the city. Inclusion criteria included age between 6 and 16
years and takingART for at least 6months.HIVuninfected children
with no known history of cardiac disease were enrolled from 7
primary care clinics in Harare serving the same catchment
population as that ofHarareHospital and from the public attending
general outpatients at Harare Hospital. Socio-demographic data,
HIV-related history, clinical signs and symptoms were collected
through a nurse-administered questionnaire. Assessments included
heart rate, respiratory rate, blood pressure (BP), and pulse oximetry.
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Blood samples were collected for measurement of HIV-1 viral load
and cluster of differentiation 4 (CD4) count testing. Carotid
ultrasound was performed using a Mindray DC N6 ultrasound
machine (Mindray, Shenzhen, China). Participants were scanned in
supine positionwith a high frequency linear array probe of 12MHz.
With thepatient’shead tiltedupwards slightly andat 45°, the left and
right common carotid arteries were examined respectively. Using
two-dimensional images in longitudinal view the carotid bulb was
identified and cine loops (10seconds long) were recorded in Dicom
format for later off-line analysis using an automated edge detection
system. Intima media thickness measurements were made at
approximately 1 to 2cm from the carotid bulb in triplicate for
each side and the average used for analysis.
The studyhad80%power todetect ameandifference in cIMTof
0.03mmandanalphaof 0.05.Unpaired t testwasused to compare
normally distributed variables and Wilcoxon rank-sum test for
variables not normally distributed between the 2 groups. Carotid
IMT measures were compared between HIV-infected versus
uninfected participants and between HIV-infected participants
receiving a protease inhibitor (PI) based regimen compared with a
non-PI regimen, using unpaired t tests. The relationship between
cIMT and clinical and HIV related factors including CD4 count,
viral load, durationofART,age, bodymass index (BMI)-for-age-z-
score and systolic BP and diastolic BPwere analyzed usingmultiple
linear regression using backward stepwise regression.
Ethical approval for this study was obtained from the Medical
Research Council of Zimbabwe, the London School of Hygiene
and Tropical Medicine Ethics Committee, the Biomedical
Research and Training Institute Institutional Review Board,
and the Harare Central Hospital Ethics Committee.
3. Results
A total of 117 participants with HIV, and 75 HIV uninfected
controls underwent cIMT scans. There was no difference by sex
between the 2 groups but participants with HIV were younger
than controls (mean [SD] age 10.7 [2.4] years vs 11.9 [2.6] years
[P= .001]); shorter (mean height-for-age-z-score –1.22 [1.0] vs –
0.29 [1.0] [P< .001]); and had lower median body mass index
(BMI) for-age z-score (–0.47 [–1.09–0.13] vs –0.17 [–0.09–0.63]
[P< .019]) (Table 1). All participants with HIV were perinatally
infected with a median age at HIV diagnosis of 5 (interquartile
range, 3–7) years. The median duration on ART was 4.8
(interquartile range 2.5–6.4) years and 24 (21%) of participants
were receiving PI as part of their ART regimen. All participants
on the PI-regimen (n=24) received atazanavir drug boosted with
ritonavir. More than 3-quarters of participants with HIV were
virally suppressed, 93 (80%).
Carotid IMT did not differ between the 2 groups: mean (SD)
0.40 (0.05)mm in those with HIV and 0.40 (0.04)mm in HIV
controls (P= .377). There was also no difference in mean cIMT
between participants who were and those who were not receiving
a PI regimen, 0.40mm versus 0.40mm (P= .809) and between
virally and non-virally suppressed (P= .514). Age, systolic BP,
BMI-for-age-z-score, CD4 count, HIV viral load, and duration
on ART were not associated with cIMT. However, diastolic BP
was associated with cIMT P= .043.
4. Discussion
We found that older children and adolescents with HIV and
receiving ART have similar cIMT to uninfected children. This
finding is consistent with other reports of children who have had
long-term exposure to ART from Indonesia and France.[7,8] Our
findings that ART-experienced children have comparable cIMT
to uninfected children could suggest that ART may protect
against atherosclerotic changes in childhood. This may be due to
slowing of arterial wall structural changes that are associated
with HIV infection. A fifth of the participants with HIV were on
PI-containing regimen, receiving atazanavir drug, which has been
reported to be less atherogenic than other PIs.[9] Data in children
from SSA is limited. In one study conducted among Zambian and
Table 1
Clinical characteristics of the participants.
Characteristics HIV infected N=117 Mean (SD) HIV uninfected N=75 Mean (SD) P-value
Female, n (%) 55 (47) 34 (45) .886
Age, y 10.7 (2.4) 11.9 (2.6) .001
Height-for-age z-score –1.22 (1.0) –0.29 (1.0) <.001
Weight-for age z-score –1.09 (1.1) –0.28 (1.0) <.001
BMI-for-age z-score, median (IQR) –0.47 (–1.09–0.13) –0.17 (–0.09–0.63) .019
Body surface area, m2 1.05 (0.2) 1.27 (0.3) <.001
Systolic BP, mmHg 110.6 (11.4) 112.6 (12.9) .267
Diastolic BP, mmHg 72.9 (9.0) 73.2 (9.8) .856
Heartrate, beats per minute 88.1 (14.5) 79.1 (14.2) <.001
Oxygen saturation, %, median (IQR) 97 (96–98) 98 (96–98) .085
cIMT, mm 0.40 (0.05) 0.40 (0.04) .472
Viral load, copies/mL, median (IQR) 19 (19–89.5)
Viral suppression, (<400 copies/mL) n (%) 93 (80)
CD4 count, cells/mL, median (IQR) 740 (513–880)
Age at HIV diagnosis, y, median (IQR) 5 (3–7)
Duration on ART, y, median (IQR) 4.8 (2.5–6.4)
ART regimen
2NRTI + PI, n (%) 24 (21)
2 NRTI + NNRTI, n (%) 88 (75)
Unknown, n (%) 5 (4)
ART= antiretroviral therapy, BMI=body mass index, BP=blood pressure, cIMT= carotid intima-media thickness, IQR= interquartile range, NNRTI=non-nucleoside reverse transcriptase, NRTI=nucleoside
reverse transcriptase, PI=protease inhibitor, SD= standard deviation, y= years.
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Ugandan children with HIV, ART-naïve children had signifi-
cantly higher cIMT, which then improved after 96 weeks of ART
initiation.[10] However, the second study conducted among
Ethiopian children found that cIMT was similar in the
participants regardless of treatment status or ART regimen.[11]
Several studies elsewhere have investigated the association
between HIV and cIMT in children and contradicting findings
have been reported. Sainz et al,[12] found that Spanish HIV
infected children and adolescents, 97% of whom were on ART
had increased cIMT thickness compared with uninfected
controls. Other studies have found increased cIMT in adult
patients receiving PI based ART regimen compared with non-PI
treated or uninfected controls.[13] Inconsistent findings in studies
investigating cIMT in HIV may be because of different
approaches in assessing cIMT,[2,3,12] the operator-dependency
of the technique or due to different underlying drivers of vessel
thickening in early life. It is also likely that the contradictory
findings in previous studies are due to the operator dependency of
ultrasound imaging.
Age and ARTwere found to be associated with increased cIMT
in a study conducted among children in United Kingdom.[2]
Vigano et al,[14] reported that HIV infection, longer duration on
ART, and male sex were associated with increased cIMT in their
cohort aged 17 to 23 from Italy. In this study, diastolic BP was
associated with cIMT and noHIV-related factors were associated
with cIMT. It is possible that our study was underpowered to
detect other associations, or it may be that differences in cIMT at
this early age may predominantly represent hypertrophy of
intimal and/or medial layers as an adaptive response to blood
flow and intraluminal pressure rather than subclinical athero-
sclerosis.[15]
Causes of subclinical atherosclerosis in HIV are likely
multifactorial. Both HIV and traditional cardiovascular risk
factors reportedly contribute to atherosclerosis in adults[4] and
others speculate that chronic inflammation may be the culprit.
Children allow the opportunity to investigate risk factors and
mechanisms of subclinical atherosclerosis without confounding
by traditional cardiovascular risk factors. There are some
limitations to this study. Ultrasound is limited as a technique
by its operator dependency. Data on lipid profiles and other
cardiovascular biomarkers are lacking and the study was cross-
sectional and therefore, no causality can be attributed to the
factors that were associated with cIMT.
5. Conclusion
Older children and adolescents withHIV and receiving ART have
similar cIMT to children without HIV. Longitudinal investiga-
tions of vascular structure and function are required to
understand whether children and adolescents in SSA receiving
ART are at increased risk of subclinical atherosclerosis.
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